[Form 4] EDGEWELL PERSONAL CARE Co Insider Trading Activity

Rhea-AI Filing Summary

Edgewell Personal Care Company (EPC) reported insider equity transactions by its Chief People & Legal Officer on 11/13/2025. A performance stock award vested, converting 5,773 performance stock equivalents into common shares at an exercise price of $0, increasing the officer’s direct holdings to 22,540 shares before related tax withholding. To cover tax liabilities on the vesting, 2,873 shares were withheld at a price of $18.39, leaving 19,667 common shares held directly afterward.

In a related equity grant dated 11/14/2025, the officer received 24,270 restricted stock equivalents at an exercise price of $0. These are scheduled to vest in three equal installments on 11/14/2026, 11/14/2027, and 11/14/2028, subject to continued employment, with potential accelerated vesting upon death, disability, change in control, or certain termination events. The original performance award was for 16,353 units, of which 10,580 were cancelled for not meeting performance criteria.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Langley LaTanya

(Last) (First) (Middle)

C/O EDGEWELL PERSONAL CARE COMPANY

6 RESEARCH DRIVE

(Street)

SHELTON CT 06484

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EDGEWELL PERSONAL CARE Co [ EPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief People & Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/13/2025		M		5,773	A	$0	22,540	D
Common Stock	11/13/2025		F		2,873(1)	D	$18.39	19,667	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Stock Award 11-11-2022	$0	11/13/2025		M			5,773	11/13/2025	(2)	Common Stock	5,773	$0	0	D
Restricted Stock Equivalents 11-14-2025	$0	11/14/2025		A		24,270		11/14/2026	(3)	Common Stock	24,270	$0	24,270	D

Explanation of Responses:

1. Shares withheld as payment of a tax liability on vesting of performance stock equivalents.

2. Performance Stock Equivalents vested and converted into shares of EPC common stock on 11/13/2025. The original award was 16,353 shares; only 5,773 vested in accordance with the performance criteria. The remaining 10,580 shares were cancelled.

3. One-third of the RSEs will vest and convert into shares of Edgewell common stock on each of 11/14/2026, 11/14/2027 and 11/14/2028 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events.

	/s/ LaTanya Langley	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.